All In MedTech

Device Trial Radar · NCT07484191

Contralateral Claims Study of Clareon Vivity Pro

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 165 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

165

Actual

Start

Apr 28, 2026

Primary completion

Oct 28, 2026

Study completion Feb 2027

Sponsor

Lead sponsor
Alcon ResearchNot on our public-company list
Sponsor type
Industry
First posted
Mar 20, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to test new versions of Clareon Vivity Pro intraocular lenses (IOLs) by comparing them to currently marketed IOLs.

Conditions

  • Aphakia
  • Presbyopia

Interventions

  • Clareon Vivity Pro IOLDevice

    Investigational UV-absorbing, blue-light filtering (BLF), foldable IOL that provides an extended range of vision from distance to near without increasing the incidence of visual disturbances. IOLs are implantable medical devices and are intended for long term use over the lifetime of the pseudophakic subject.

  • Clareon Vivity IOLDevice

    Currently marketed UV-absorbing, BLF, foldable IOL that provides an extended range of vision from distance to functional near without increasing the incidence of visual disturbances. IOLs are implantable medical devices and are intended for long term use over the lifetime of the pseudophakic subject.

  • TECNIS PureSee IOLDevice

    Currently marketed UV absorbing, violet-light filtering IOL for primary implantation for the visual correction of aphakia in adult patients with and without presbyopia. IOLs are implantable medical devices and are intended for long term use over the lifetime of the pseudophakic subject.

  • Cataract SurgeryProcedure

    Removal of the cloudy lens, followed by implantation of the IOL

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean monocular photopic distance-corrected intermediate visual acuity (DCIVA)Time frame: Month 1 postoperative

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • iVision Clinic

    Campsie, New South Wales, Australia

  • Vision Eye Institute - Chatswood

    Sydney, New South Wales, Australia

  • Personaleyes Parramatta

    Sydney, New South Wales, Australia

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.